[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IS8053A - Tilbúin gen sem tákna mennskt krabbameinsfósturvísa mótefni og notkun þeirra - Google Patents

Tilbúin gen sem tákna mennskt krabbameinsfósturvísa mótefni og notkun þeirra

Info

Publication number
IS8053A
IS8053A IS8053A IS8053A IS8053A IS 8053 A IS8053 A IS 8053A IS 8053 A IS8053 A IS 8053A IS 8053 A IS8053 A IS 8053A IS 8053 A IS8053 A IS 8053A
Authority
IS
Iceland
Prior art keywords
embryos
genes
human carcinoma
represent human
represent
Prior art date
Application number
IS8053A
Other languages
English (en)
Inventor
La Monica Nicola
Lahm Armin
Mennuni Carmela
Savino Rocco
Original Assignee
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa filed Critical Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa
Publication of IS8053A publication Critical patent/IS8053A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IS8053A 2003-05-05 2005-09-29 Tilbúin gen sem tákna mennskt krabbameinsfósturvísa mótefni og notkun þeirra IS8053A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46797103P 2003-05-05 2003-05-05
US54361204P 2004-02-11 2004-02-11
PCT/EP2004/004802 WO2004099247A2 (en) 2003-05-05 2004-05-03 Synthetic gene encoding human carcinoembryonic antigen and uses thereof

Publications (1)

Publication Number Publication Date
IS8053A true IS8053A (is) 2005-09-29

Family

ID=33436748

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8053A IS8053A (is) 2003-05-05 2005-09-29 Tilbúin gen sem tákna mennskt krabbameinsfósturvísa mótefni og notkun þeirra

Country Status (12)

Country Link
US (1) US20070104685A1 (is)
EP (1) EP1622937A2 (is)
JP (1) JP2007523610A (is)
KR (1) KR20060003903A (is)
CN (1) CN1784424A (is)
AU (1) AU2004235943A1 (is)
CA (1) CA2523720A1 (is)
IS (1) IS8053A (is)
NO (1) NO20055708L (is)
NZ (1) NZ543922A (is)
RU (1) RU2005137697A (is)
WO (1) WO2004099247A2 (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005019455A1 (en) * 2003-08-22 2005-03-03 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof
AU2005212479B2 (en) * 2004-02-11 2009-09-10 Msd Italia S.R.L. Carcinoembryonic antigen fusion proteins and uses thereof
JP4881623B2 (ja) * 2006-01-27 2012-02-22 シスメックス株式会社 Ｃｅａ核酸増幅用プライマー、プライマーセット、及びがんの診断支援方法
EP1981533A1 (en) * 2006-02-06 2008-10-22 Medizinische Universität Wien Vaccine and antigen mimotopes against cancerous diseases associated with the carcinoembryonic antigen cea
WO2009006479A2 (en) 2007-07-02 2009-01-08 Etubics Corporation Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
JP5352586B2 (ja) * 2007-07-27 2013-11-27 イマティクス バイオテクノロジーズ ゲーエムベーハー 腫瘍関連ペプチドおよび関連抗癌ワクチンの組成物
WO2009117656A2 (en) * 2008-03-21 2009-09-24 Vectorlogics,Inc. Capsid-incorporated antigen for novel adenovirus vaccine
KR101815322B1 (ko) * 2010-01-12 2018-01-05 서울대학교산학협력단 항암 펩타이드 서열
US9605276B2 (en) * 2012-08-24 2017-03-28 Etubics Corporation Replication defective adenovirus vector in vaccination
CN107530383A (zh) 2015-01-09 2018-01-02 埃图比克斯公司 用于埃博拉病毒疫苗接种的方法和组合物
JP6647315B2 (ja) 2015-01-09 2020-02-14 イーチュービクス コーポレイション 組み合わせ免疫療法のための方法および組成物
EP3286213B1 (en) 2015-04-20 2021-08-04 Etubics Corporation Methods and compositions for combination immunotherapy
CA3115658A1 (en) * 2018-10-12 2020-05-22 Children's Hospital Medical Center Modular expression systems for gene expression and methods of using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795737A (en) * 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
DE10055545A1 (de) * 2000-11-09 2002-07-25 Deutsches Krebsforsch Für Expression in Eukaryonten optimierte HPV 16-L1 und HPV 16-L2 kodierende DNA Sequenzen

Also Published As

Publication number Publication date
RU2005137697A (ru) 2006-05-10
WO2004099247A3 (en) 2005-02-24
AU2004235943A1 (en) 2004-11-18
NO20055708L (no) 2006-02-06
NZ543922A (en) 2008-05-30
CA2523720A1 (en) 2004-11-18
CN1784424A (zh) 2006-06-07
WO2004099247A2 (en) 2004-11-18
JP2007523610A (ja) 2007-08-23
EP1622937A2 (en) 2006-02-08
KR20060003903A (ko) 2006-01-11
US20070104685A1 (en) 2007-05-10
NO20055708D0 (no) 2005-12-02

Similar Documents

Publication Publication Date Title
NO2017017I1 (no) umeklinidium og vilanterol
NL350092I2 (nl) Combinatie van bixafen en fluoxastrobine
DK1583542T3 (da) Sammensætninger og fremgangsmåder til antiviral kombinationsterapi
IS8434A (is) Verndandi vírnet, verndandi formgerð búin til meðnetinu og notkunin á verndandi vírnetinu við að búa til verndandi formgerð
NO20055837D0 (no) Immunsupprimerende forbindelser og sammensetninger
DK1644021T3 (da) Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
DK1682841T3 (da) Flowfordelingsenhed og köleenhed
EE200500035A (et) Personaalne teraapiasektsioon
DK1713544T3 (da) Sammensætninger og fremgangsmåder til oral og personlig pleje
IS8597A (is) Samsetningar rísedrónats og aðferðir við notkun þess
IS7348A (is) N-pýrasínýl-fenýlsúlfónamíð og notkun þeirra til að meðhöndla flakkboðatengda sjúkdóma
DE60326145D1 (de) Spielermittlungsverfahren
DE60327254D1 (de) Den getreideertrag erhöhendes gen und dessen nutzung
IS8053A (is) Tilbúin gen sem tákna mennskt krabbameinsfósturvísa mótefni og notkun þeirra
DK1771421T3 (da) N-hydroxyamidderivater og anvendelse deraf
DE602005020202D1 (de) Getrennter Steckverbinder und Verbindereinrichtung
IS8489A (is) Umritunarstillar og aðferðir þeirra
GB0308382D0 (en) Therapeutic methods and means
ATE460415T1 (de) Therapeutische pyrazoloä3,4-büpyridine und - indazole
PL1786431T3 (pl) Ulepszone preparaty fotouczulaczy i ich zastosowanie
NO20055668D0 (no) Beta-amyloidinhibitorer og anvendelse derav
GB0321694D0 (en) Genes and their therapeutic use
IS8391A (is) Notkun á síramesíni við meðhöndlun á krabbameini
NO20054160D0 (no) Imidazopyridin-inneholdende kombinasjoner og deres anvendelse i behandling av gastrointestinale inflammatoriske lidelser
IS7285A (is) Innmötun og dreifing